Published in J Leukoc Biol on January 01, 1995
Myocardial ischemic memory imaging with molecular echocardiography. Circulation (2007) 2.13
Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest (1995) 2.06
Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest (2007) 2.03
Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J (1997) 1.65
Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol (2001) 1.13
Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol (1999) 1.05
Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med (1999) 1.03
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol (1999) 0.99
Detection of antecedent myocardial ischemia with multiselectin molecular imaging. J Am Coll Cardiol (2012) 0.93
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists. Cardiovasc Res (2008) 0.90
ITF1697, a stable Lys-Pro-containing peptide, inhibits weibel-palade body exocytosis induced by ischemia/reperfusion and pressure elevation. Mol Med (2007) 0.89
Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x. Br J Pharmacol (1999) 0.83
Astragalus Polysaccharide Suppresses the Expression of Adhesion Molecules through the Regulation of the p38 MAPK Signaling Pathway in Human Cardiac Microvascular Endothelial Cells after Ischemia-Reperfusion Injury. Evid Based Complement Alternat Med (2013) 0.81
Mechanisms related to the cardioprotective effects of protein kinase C epsilon (PKC epsilon) peptide activator or inhibitor in rat ischemia/reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.81
Upregulation of coronary endothelial P-selectin in a monkey heart ischemia reperfusion model. J Mol Histol (2010) 0.79
The effects of modulating eNOS activity and coupling in ischemia/reperfusion (I/R). Naunyn Schmiedebergs Arch Pharmacol (2011) 0.78
Pulmonary endothelial activation caused by extracellular histones contributes to neutrophil activation in acute respiratory distress syndrome. Respir Res (2016) 0.75
P-selectin expression in cold preserved kidneys in University of Wisconsin and histidine-tryptophan-ketoglutarate solutions. J Surg Res (2009) 0.75
Ultrasound detection of myocardial ischemic memory using an e-selectin targeting Peptide amenable to human application. Mol Imaging (2014) 0.75
Cardioprotective actions of oligotide, a single stranded polydeoxyribonucleotide complex, in myocardial ischaemia and reperfusion injury. Br J Pharmacol (1996) 0.75
Generation and characterization of feline arterial and venous endothelial cell lines for the study of the vascular endothelium. BMC Vet Res (2013) 0.75
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J (1998) 4.46
Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest (1991) 2.17
Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation (1995) 2.08
Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology (1994) 2.07
Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A (1995) 1.98
Transient induction of TGF-alpha disrupts lung morphogenesis, causing pulmonary disease in adulthood. Am J Physiol Lung Cell Mol Physiol (2004) 1.84
Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol (2000) 1.82
In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest (1993) 1.80
Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation (2000) 1.76
Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63
Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62
Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56
Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J (1992) 1.53
Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med (2001) 1.52
Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52
Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48
Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol (1979) 1.47
Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47
Circulating neutrophil concentration and respiratory distress in premature infants. J Pediatr (2000) 1.45
Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics (2005) 1.43
Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin. Crit Care Med (2001) 1.43
Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat. Circ Res (1974) 1.40
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation (1992) 1.40
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39
[Infective endocarditis : emergency treatment and long-term surveillance]. Internist (Berl) (2013) 1.39
Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci U S A (1997) 1.38
Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37
A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis (1992) 1.34
Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation (2001) 1.34
Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med (1991) 1.33
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Presence of a myocardial depressant factor in patients in circulatory shock. Surgery (1971) 1.28
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation (1992) 1.28
Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther (1990) 1.26
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24
Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest (1989) 1.24
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab (2001) 1.23
Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther (1992) 1.22
Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol (1994) 1.21
Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol (1997) 1.21
Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol (1989) 1.21
VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol (2004) 1.20
Blood-borne humoral factors in the pathophysiology of circulatory shock. Circ Res (1973) 1.18
Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol (1998) 1.15
Quantification of damage by air emboli to lung microvessels in anesthetized sheep. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.15
Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation (1993) 1.13
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol (2001) 1.13
Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 1.12
Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation (2000) 1.12
Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc (1971) 1.11
Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol (1989) 1.11
Antibodies which antagonise the effects of prostacyclin. Nature (1978) 1.10
Origin of myocardial depressant factor in shock. Am J Physiol (1970) 1.09
Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res (1994) 1.09
A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis (1997) 1.09
Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol (1995) 1.08
Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock. Surgery (1971) 1.08
Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol (1999) 1.08
Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol (1998) 1.05
C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J (2000) 1.05
Direct measurement of nitric oxide release from vascular endothelial cells. J Appl Physiol (1985) (1996) 1.05
Role of lysosomes in the pathogenesis of splanchnic ischemia shock in cats. Circ Res (1970) 1.05
Structure, blood supply, and lymphatic vessels of the sheep's visceral pleura. Am J Anat (1982) 1.05
Endothelial activation in ARDS. Chest (1999) 1.04
Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation (1997) 1.04
Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. J Pharmacol Exp Ther (1988) 1.04
Pathophysiological mechanisms of sudden death induced by platelet activating factor. Br J Pharmacol (1984) 1.04
Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med (1999) 1.03
Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation (1997) 1.03
Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol (1983) 1.03
Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol (1996) 1.02
Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res (1994) 1.02
Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res (1996) 1.02
P-selectin expression by endothelial cells is decreased in neonatal rats and human premature infants. Blood (1999) 1.02
Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol (1980) 1.02
Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Arterioscler Thromb Vasc Biol (2000) 1.01
NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thromb Res (2000) 1.01
Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol (1992) 1.01
Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. Science (1986) 1.01
Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep. J Clin Invest (1988) 1.01
Relationship of plasma peptides to the myocardial depressant factor in hemorrhagic shock in cats. Circ Res (1970) 1.00
Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol (1990) 1.00
Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res (1999) 0.99
Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res (2000) 0.99
Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol (2001) 0.99
Leucocytes and pulmonary microvascular injury. Ann N Y Acad Sci (1982) 0.99
Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ Res (1980) 0.98
Actions of prostaglandins on isolated perfused cat coronary arteries. Am J Physiol (1978) 0.98
Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion. Am J Respir Cell Mol Biol (1997) 0.98
Upregulation of alveolar epithelial fluid transport after subacute lung injury in rats from bleomycin. Am J Physiol (1998) 0.98
Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. J Mol Cell Cardiol (1996) 0.98
Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. Proc Soc Exp Biol Med (1988) 0.97
Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h. J Appl Physiol (1985) (1989) 0.97
Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res (1991) 0.97